NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » Industry news » Contract Research Orgs back to previous page show list
TOP NEWS
Sundia MediTech Company,Ltd.
»01/09/2009 [Industry news]
Sundia gets the (Highest Growth Potential) award

Sundia MediTech, a pharmaceutical R&D outsourcing company in China, has received the Highest Growth Potential Award from Zhangjiang Hi-Tech Park on August 26.

 
Sundia MediTech, a pharmaceutical R&D outsourcing company in China, has received the Highest Growth Potential Award from Zhangjiang Hi-Tech Park on August 26. The award was announced at the 10th anniversary celebration of \"Focus on Zhangjiang Festival\" in August. Dr Tong Xu, Sundia\'s Vice President for Process Chemistry and GMP Operations, who attended the ceremony said, \"Zhangjiang Hi-Tech Park is China\'s most successful high technology park which many top high tech start-up companies in China have chosen as their home. I am honored to be here today to receive this award for Sundia.\" In August 1999, Shanghai Municipal Government declared a \"Focus on Zhangjiang\" strategy to utilize all resources of the city with support from the central Chinese government to make Zhangjiang Park the technology innovation highland of the country. Ten years later, Zhangjiang has become the national biotech & pharmaceutical industry base, which has attracted more than 300 biotech and pharmaceutical companies from all over the world. According to Sundia, it has kept a high speed for business growth in the past five years. For the year 2008, Sundia ranked 52nd in Deloitte technology Fast 500 Asia Pacific list, and 16th in Fast 50 China list, with a estimated 928 percent revenue growth. It was also named one of the 50 best companies for investment in 2007 and 2008. \"We are lucky that we made the decision to come to Zhangjiang to start Sundia five years ago,\" said Dr Wang Xiaochuan, Sundia\'s Chairman. \"Zhangjiang Hi-Tech Park announced a New Drug Incubation Platform earlier this year to combine venture capitals, intellectual properties, and CRO resources together to support new drug discovery and development programs in the park. Sundia was selected by Zhangjiang as the leading CRO provider to this platform based on our outstanding track record in CRO services. We will try our best to support Zhangjiang Hi-Tech Park to make this platform a success.\"

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.